Effects of community-wide vaccination with PCV-7 on pneumococcal nasopharyngeal carriage in the Gambia: a cluster-randomized trial.
BACKGROUND: Introduction of pneumococcal conjugate vaccines (PCVs) of limited valency is justified in Africa by the high burden of pneumococcal disease. Long-term beneficial effects of PCVs may be countered by serotype replacement. We aimed to determine the impact of PCV-7 vaccination on pneumococca...
| Автори: | , , , , , , , , , , , , |
|---|---|
| Формат: | Journal article |
| Мова: | English |
| Опубліковано: |
Public Library of Science
2011
|
| _version_ | 1826265999193669632 |
|---|---|
| author | Roca, A Hill, P Townend, J Egere, U Antonio, M Bojang, A Akisanya, A Litchfield, T Nsekpong, D Oluwalana, C Howie, SR Greenwood, B Adegbola, R |
| author_facet | Roca, A Hill, P Townend, J Egere, U Antonio, M Bojang, A Akisanya, A Litchfield, T Nsekpong, D Oluwalana, C Howie, SR Greenwood, B Adegbola, R |
| author_sort | Roca, A |
| collection | OXFORD |
| description | BACKGROUND: Introduction of pneumococcal conjugate vaccines (PCVs) of limited valency is justified in Africa by the high burden of pneumococcal disease. Long-term beneficial effects of PCVs may be countered by serotype replacement. We aimed to determine the impact of PCV-7 vaccination on pneumococcal carriage in rural Gambia. METHODS AND FINDINGS: A cluster-randomized (by village) trial of the impact of PCV-7 on pneumococcal nasopharyngeal carriage was conducted in 21 Gambian villages between December 2003 to June 2008 (5,441 inhabitants in 2006). Analysis was complemented with data obtained before vaccination. Because efficacy of PCV-9 in young Gambian children had been shown, it was considered unethical not to give PCV-7 to young children in all of the study villages. PCV-7 was given to children below 30 mo of age and to those born during the trial in all study villages. Villages were randomized (older children and adults) to receive one dose of PCV-7 (11 vaccinated villages) or meningococcal serogroup C conjugate vaccine (10 control villages). Cross-sectional surveys (CSSs) to collect nasopharyngeal swabs were conducted before vaccination (2,094 samples in the baseline CSS), and 4-6, 12, and 22 mo after vaccination (1,168, 1,210, and 446 samples in CSS-1, -2, and -3, respectively). A time trend analysis showed a marked fall in the prevalence of vaccine-type pneumococcal carriage in all age groups following vaccination (from 23.7% and 26.8% in the baseline CSS to 7.1% and 8.5% in CSS-1, in vaccinated and control villages, respectively). The prevalence of vaccine-type pneumococcal carriage was lower in vaccinated than in control villages among older children (5 y to <15 y of age) and adults (≥15 y of age) at CSS-2 (odds ratio [OR] = 0.15 [95% CI 0.04-0.57] and OR = 0.32 [95% CI 0.10-0.98], respectively) and at CSS-3 (OR = 0.37 [95% CI 0.15-0.90] for older children, and 0% versus 7.6% for adults in vaccinated and control villages, respectively). Differences in the prevalence of non-vaccine-type pneumococcal carriage between vaccinated and control villages were small. CONCLUSIONS: Vaccination of Gambian children reduced vaccine-type pneumococcal carriage across all age groups, indicating a "herd effect" in non-vaccinated older children and adults. No significant serotype replacement was detected. Please see later in the article for the Editors' Summary. |
| first_indexed | 2024-03-06T20:32:19Z |
| format | Journal article |
| id | oxford-uuid:3174159a-d311-4538-b1e7-ec8f19a37f47 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-06T20:32:19Z |
| publishDate | 2011 |
| publisher | Public Library of Science |
| record_format | dspace |
| spelling | oxford-uuid:3174159a-d311-4538-b1e7-ec8f19a37f472022-03-26T13:08:11ZEffects of community-wide vaccination with PCV-7 on pneumococcal nasopharyngeal carriage in the Gambia: a cluster-randomized trial.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:3174159a-d311-4538-b1e7-ec8f19a37f47EnglishSymplectic Elements at OxfordPublic Library of Science2011Roca, AHill, PTownend, JEgere, UAntonio, MBojang, AAkisanya, ALitchfield, TNsekpong, DOluwalana, CHowie, SRGreenwood, BAdegbola, RBACKGROUND: Introduction of pneumococcal conjugate vaccines (PCVs) of limited valency is justified in Africa by the high burden of pneumococcal disease. Long-term beneficial effects of PCVs may be countered by serotype replacement. We aimed to determine the impact of PCV-7 vaccination on pneumococcal carriage in rural Gambia. METHODS AND FINDINGS: A cluster-randomized (by village) trial of the impact of PCV-7 on pneumococcal nasopharyngeal carriage was conducted in 21 Gambian villages between December 2003 to June 2008 (5,441 inhabitants in 2006). Analysis was complemented with data obtained before vaccination. Because efficacy of PCV-9 in young Gambian children had been shown, it was considered unethical not to give PCV-7 to young children in all of the study villages. PCV-7 was given to children below 30 mo of age and to those born during the trial in all study villages. Villages were randomized (older children and adults) to receive one dose of PCV-7 (11 vaccinated villages) or meningococcal serogroup C conjugate vaccine (10 control villages). Cross-sectional surveys (CSSs) to collect nasopharyngeal swabs were conducted before vaccination (2,094 samples in the baseline CSS), and 4-6, 12, and 22 mo after vaccination (1,168, 1,210, and 446 samples in CSS-1, -2, and -3, respectively). A time trend analysis showed a marked fall in the prevalence of vaccine-type pneumococcal carriage in all age groups following vaccination (from 23.7% and 26.8% in the baseline CSS to 7.1% and 8.5% in CSS-1, in vaccinated and control villages, respectively). The prevalence of vaccine-type pneumococcal carriage was lower in vaccinated than in control villages among older children (5 y to <15 y of age) and adults (≥15 y of age) at CSS-2 (odds ratio [OR] = 0.15 [95% CI 0.04-0.57] and OR = 0.32 [95% CI 0.10-0.98], respectively) and at CSS-3 (OR = 0.37 [95% CI 0.15-0.90] for older children, and 0% versus 7.6% for adults in vaccinated and control villages, respectively). Differences in the prevalence of non-vaccine-type pneumococcal carriage between vaccinated and control villages were small. CONCLUSIONS: Vaccination of Gambian children reduced vaccine-type pneumococcal carriage across all age groups, indicating a "herd effect" in non-vaccinated older children and adults. No significant serotype replacement was detected. Please see later in the article for the Editors' Summary. |
| spellingShingle | Roca, A Hill, P Townend, J Egere, U Antonio, M Bojang, A Akisanya, A Litchfield, T Nsekpong, D Oluwalana, C Howie, SR Greenwood, B Adegbola, R Effects of community-wide vaccination with PCV-7 on pneumococcal nasopharyngeal carriage in the Gambia: a cluster-randomized trial. |
| title | Effects of community-wide vaccination with PCV-7 on pneumococcal nasopharyngeal carriage in the Gambia: a cluster-randomized trial. |
| title_full | Effects of community-wide vaccination with PCV-7 on pneumococcal nasopharyngeal carriage in the Gambia: a cluster-randomized trial. |
| title_fullStr | Effects of community-wide vaccination with PCV-7 on pneumococcal nasopharyngeal carriage in the Gambia: a cluster-randomized trial. |
| title_full_unstemmed | Effects of community-wide vaccination with PCV-7 on pneumococcal nasopharyngeal carriage in the Gambia: a cluster-randomized trial. |
| title_short | Effects of community-wide vaccination with PCV-7 on pneumococcal nasopharyngeal carriage in the Gambia: a cluster-randomized trial. |
| title_sort | effects of community wide vaccination with pcv 7 on pneumococcal nasopharyngeal carriage in the gambia a cluster randomized trial |
| work_keys_str_mv | AT rocaa effectsofcommunitywidevaccinationwithpcv7onpneumococcalnasopharyngealcarriageinthegambiaaclusterrandomizedtrial AT hillp effectsofcommunitywidevaccinationwithpcv7onpneumococcalnasopharyngealcarriageinthegambiaaclusterrandomizedtrial AT townendj effectsofcommunitywidevaccinationwithpcv7onpneumococcalnasopharyngealcarriageinthegambiaaclusterrandomizedtrial AT egereu effectsofcommunitywidevaccinationwithpcv7onpneumococcalnasopharyngealcarriageinthegambiaaclusterrandomizedtrial AT antoniom effectsofcommunitywidevaccinationwithpcv7onpneumococcalnasopharyngealcarriageinthegambiaaclusterrandomizedtrial AT bojanga effectsofcommunitywidevaccinationwithpcv7onpneumococcalnasopharyngealcarriageinthegambiaaclusterrandomizedtrial AT akisanyaa effectsofcommunitywidevaccinationwithpcv7onpneumococcalnasopharyngealcarriageinthegambiaaclusterrandomizedtrial AT litchfieldt effectsofcommunitywidevaccinationwithpcv7onpneumococcalnasopharyngealcarriageinthegambiaaclusterrandomizedtrial AT nsekpongd effectsofcommunitywidevaccinationwithpcv7onpneumococcalnasopharyngealcarriageinthegambiaaclusterrandomizedtrial AT oluwalanac effectsofcommunitywidevaccinationwithpcv7onpneumococcalnasopharyngealcarriageinthegambiaaclusterrandomizedtrial AT howiesr effectsofcommunitywidevaccinationwithpcv7onpneumococcalnasopharyngealcarriageinthegambiaaclusterrandomizedtrial AT greenwoodb effectsofcommunitywidevaccinationwithpcv7onpneumococcalnasopharyngealcarriageinthegambiaaclusterrandomizedtrial AT adegbolar effectsofcommunitywidevaccinationwithpcv7onpneumococcalnasopharyngealcarriageinthegambiaaclusterrandomizedtrial |